Tazocin misconceptions: misuse in community-acquired pneumonia – spectrum too broad
Piperacillin+tazobactam (Tazocin) is an important broad spectrum antibiotic that is still active in most Australian settings against a wide range of Gram negatives (including Pseudomonas) , Gram positives (excluding MRSA and VRE) and nearly all anaerobic bacteria. It comes into great demand for management of a range of healthcare-associated infections, especially in ICU. Its use […]
Piperacillin+tazobactam shortage – recommended alternatives – HNELHD
SITUATION Due to a global shortage, many Hunter New England Local Health District sites have low supplies of piperacillin+tazobactam with shortages likely until after September. It is essential that further use of this agent is conserved as below. Amoxycillin+clavulanate is now available in a parenteral form and is a suitable option in many circumstances, contingent on local […]
Overuse => global shortage! Let’s conserve what piperacillin+tazobactam we have left
Piperacillin+tazobactam (Tazocin) is one of our most important broad spectrum agents and is in short supply. Please conserve it by avoiding use in these common situations: Uncomplicated biliary sepsis (Use ampicillin+gentamicin(max 48hrs) OR if allergic, ceftriaxone) Urinary tract infection with sepsis (Use ampicillin+gentamicin(max 48 hrs) OR if allergic, ceftriaxone) Early onset (< 5d after admission) […]
AAW on AIMED: our top ten posts
Just in case you missed them, here are the top ten most visited posts we have published over the last year. Special thanks to our audience – we target local prescribers and pharmacists primarily. We also appreciate the interactions with our international audience!
AIMED - Let's talk about antibiotics 